Changes in lifestyle for therapy of coronary heart disease;Lebensstilanderung als kausaler therapieansatz der koronaren herzkrankheit

Zeitschrift fur Kardiologie

Volumn 87, Issue SUPPL. 2, 1998, Pages 125-135

  Gleichmann, U ^a   Gleichmann, S ^a   Mannebach, H ^a   Baller, D ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cholesterol; Coronary heart disease; Homocysteinaemia; Hypertension; Life style; Weight control

Indexed keywords

ACETYLSALICYLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LIFESTYLE; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; SMOKING CESSATION; WEIGHT REDUCTION;

CORONARY DISEASE; HUMANS; LIFE STYLE; RISK FACTORS;

EID: 0031757920     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Alfthan G, Gey K (1997) Plasma homocysteine and cardiovascular disease mortality. Lancet 349: 397
2. Assmann G, Berg A, Breithardt G, Gleichmann U, Halhuber M, Keil U, Kochsiek K, Kruse-Jarres J, Lichtlen P, Schlierf G, Schwandt P, Weidemann H, Wisser H (1990) Nationale Cholesterin-Initiative. Ein Strategiepapier zur Erkennung und Behandlung von Hyperlipidämien. Dtsch Ärzteblatt 87: 1358-1382
3. Becher H, Wahrendorf J (1994) Passivrauchen und Lungenkrebsrisiko. Gegenwärtiger epidemiologischer Erkenntnisstand und Abschätzung des Effektes in der Bundesrepublik Deutschland. Deutsch Ärzteblatt 31: B.2455-B.2459
4. Beilin L (1994) Non-pharmacological management of hypertension. In: Swales J (ed) Textbook of hypertension. Blackwell, Oxford, pp ••••
5. Black HR (1993) Treatment of mild hypertension. The more things change... (Editorial). JAMA 270: 757-759
6. Buchkremer G, Rath N (1989) Raucherentwöhnung. Psychologische und Pharmakologische Methoden. Thieme, Stuttgart, New York
7. Cutler JA, Grandits GA, Grimm RA, Thomas HE, Billings JH, Wright NH (1991) Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial. Preventive Med 20: 183-196
8. Daly L, Mulcahy R, Graham I, Hickey N (1983) Longterm effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J 287: 324-326
9. Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350: 430-436
10. Davis BR, Blaufox MD, Oberman A, Wassertheil-Smoller S, Zimbaldi N, Cutler JA, Kirchner K, Lanngford HG (1993) Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Arch Intern Med 153: 1773-1782
11. DeFronzo R, Ferranini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194
12. Denke M (1995) Cholesterol-lowering diets. A review of evidence. Arch Intern Med 155: 17-26
13. Deutsche Gesellschaft für Ernährung (1992) Ernährungsbericht 1992. Frankfurt
14. Dötsch D, Gleichmann U, Großklaus R, Kluthe R, Ummenhofer C (1994) 1. Consensuskonferenz der Deutschen Akademie für Ernährungsmedizin: Stellenwert der Kochsalzrestriktion in der Prävention und Therape der Hypertonie. Akt Ernähr Med 19: 40-41
15. European Atherosclosis Society and International Task Force (1992) Prevention of coronary heart disease: scientific background and clinical guidelines. NMCD 2: 113-156
16. Glantz S, Parmley (1995) Passive smoking and heart disease. Mechanisms and risk. JAMA 273: 1047-1053
17. Gleichmann S, Eckert S, Gleichmann U, Vetter W (1994) Blutdruckselbstmessung, Standortbestimmung und Perspektiven 1994. Steinkopff, Darmstadt
18. Gleichmann S, Eckert S, Milau C, Gleichmann U (1997) How effective is relaxation therapy by Jacobson/Bernstein/Borkovec on acute blood pressure variation (beat-to-beat) in hypertensives. Montreal: The 4th International Conference on Preventive Cardiology
19. Gleichmann S, Gleichmann U (1988) Bedeutung der Ernährung für die Enstehung und Therapie der Hypertonie. Nieren-Hochdruckkrankheiten 17: 470-477
20. Gleichmann S, Gleichmann U (1991) Patientenedukation bei Hypertonie - Welche Methoden sind praxisgerecht? Internist 32: 119-126
21. Gleichmann U, Mannebach H, Gleichmann S (1984) Prävention der KHK, praktische Gesichtspunkte. Z Kardiol 73 (Suppl 2): 143-148
22. Gleichmann U, Mannebach H, Gleichmann S (1991) Kontrolle von Risikofaktoren bei dokumentierter koronarer Herzkrankheit. Konsequenzen für die Praxis. In: Gleichmann U, Mannebach H, Gleichmann S, Held K (Hrsg.) Herausforderung Atherosklerose in den 90ern. Gesundheit fördern - Krankheit mindern. Steinkopff Verlag, Darmstadt, S 35-43
23. Gleichmann U, Mannebach H, Gleichmann S (1994) Sekundäre Prävention bei dokumentierter koronarer Herzkrankheit (KHK), Konsequenzen für den praktisch tätigen Arzt. In: Kolenda K-D (Hrsg.) Lebensstil und koronare Herzkrankheit. PERIMED-spitta, Balingen, S 56-65
24. Gleichmann U, Mannebach H, Gleichmann S, Baller D (1996) Prävention von Herzerkrankungen. In: Peter H, Pfreundschuh M, Philipp T, Schölmerich J, Schuster H, Sybrecht G (Hrsg.) Klinik der Gegenwart. Urban & Schwarzenberg, München, Wien, Baltimore, S 13: 1-43
25. Gleichmann U, Philippi H, Gleichmann S, Laun R, Mannebach H, Mellwig K, Frohnapfel F, Liebermann A (1989) Optimierte Langzeitkontrolle der arteriellen Hypertonie. Erfahrungen mit ambulanten, sport-orientierten Hochdruckgruppen. Dtsch Med Wschr 114: 815-820
26. Gleichmann U, Philippi H, Gleichmann S, Laun R, Mellwig K, Frohnapfel F, Liebermann A (1989) Group exercise improves patient compliance in mild to moderate hypertension. J Hypertension 7 (suppl 3): 77-80
27. Gloag D (1992) Exercise, fitness, and health. People need to be more active more often. Editoral. Br Med J 305: 377-378
28. Gohlke H (1992) Strategien zur Verminderung des Nikotinabusus bei Patienten mit kardiovaskulären Erkrankungen. In: Gleichmann S, Wambach G (Hrsg.) Gesundheitsbewußtsein im Krankenhaus am Beispiel der Hypertonie. Steinkopff Verlag, Darmstadt, S 37-44
29. Gotto AM (1989) Diet and cholesterol guidelines and coronary heart disease. JACC 13: 503-507
30. Grobbee D (1994) Electrolyte intake and human hypertension. In: Swales J (ed) Textbook of hypertension. Blackwell, Oxford, pp 539-566
31. Gupta S, Leatham E, Carrington D, Mendall M, Kaski J, Camm J (1997) Elevated Chlamydiae pneumoniae antibodies, cardiovascular events and azthromycin in male survivors of myocardial infarction. Circulation 96: 404-407
32. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, Group ftRS (1997) Randomised trial of roxythromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 350: 404-07
33. Hamsten A (1996) Molecular genetics as the route to understanding, prevention, and treatment. Lancet 348 (suppl I): 17-19
34. Heyden S, Gleichmann U, Gleichmann S, Schneider K (1991) Kochsalzrestriktion und Serumcholesterin bei Hypertonikern. Akt Ernähr Med 16: 103-105
35. Hjjermann I, Holme I, Leren P (1986) Oslo study diet and antsmoking trial. Amer J Med 80 (suppl 2A): 7-12
36. Hochdruckliga, V. DLzBdhBe and Hypertoniegesellschaft D (1994) Alkohol und Hochdruck. Heidelberg
37. Hodis H, WJ M, LaBree L, Cashin-Hemphill L, Sevanian A, Johnson R, Azen P (1995) Serial coronary angiographie evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273: 1849-1854
38. Hoffman R, Garewell H (1995) Antioxydants and the prevention of coronary heart disease. Arch Intern Med 155: 241-246
39. Hoffmeister H, Mensink G, Stolzenberg H (1994) National trends in risk factors for cardiovascular disease in Germany. Prev Med 23: 197-205
40. Hunink M, Goldman L, Toleson A, Mitleman M, Goldman P, Williams L, Tsevat J, Weinstein M (1997) The recent decline in mortality from coronary heart disease, 1980-90 the effect of secular trends in risk factors and treatment. JAMA 277: 535-542
41. Janka H (1992) Metabolisches Syndrom und Typ-II-Diabetes, Beziehungen zur Makroangiopathie. Fortschr Med 110: 637-640
42. JNC-V: and Joint National Committee on Detection E, and Treatment of High Blood Pressure (1993) The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 153: 154-183
43. Kannel WB (1990) Coronary disease and risk factor intervention. Cardiovasc. Risk Factors 1: 14-24
44. Kempner W ( 1948) Treatment of hypertensive vascular disease with rice diet. Am J Med 4: 545-551
45. Kokkinos P, Holland J, Narayan P, Colleran J, Dotson C, Papademetriou V (1995) Miles run per week and high-density lipoprotein cholesterol levels in healthy, middle aged men. A dose-resonse relationship. Arch Intern Med 155: 415-420
46. Koneckey N, Malinow M, Tunick P, Freedberg R, Rosenzweig B, Katz E, Hess D, Upson B, Leung B, Perez J, Kronzo I (1997) Correlation between plasma homocyst(e)in and aortic atherosclerosis. Am Heart J 133: 534-540
47. Kornhuber H (1986) Bluthochdruck und Alkoholkonsum. In: Rosenthal J (Hrsg.) Arterielle Hypertonie. Springer Verlag, Berlin, Heidelberg, New York
48. Kromhout D (1996) Diet-heart isssues in a pharmacological era. Lancet 348 (suppl I): 20-22
49. Kromhout D, Menotti A, Bloemberg B et al. (1995) Dietary saturated and tranfatty-acids and cholesterol and 25-year mortality from coronary heart disease: The Seven Countries Study. Prev Med 24: 308-315
50. LaRosa J and Cleeman J (1992) Cholesterol lowering as a treatment for established coronary heart disease. Circulation 85: 1239-1235
51. Law M, Frost C, Wald N (1991) By how much does dietary salt reduction lower blood pressure? I -A nalysis of observational data among populations. BMJ 302: 811-815
52. Lee I-M, Hsieh C, Paffenbarger R (1995) Exercise intensity and longevity in men. The Harvard alumni health study. JAMA 273: 1179-1184
53. Lyp G, Beevers D (1997) Can we treat coronary artery disease with antibiotics? Lancet 350: 378-79
54. McCarron D, Oparil S, Chait A, Haynes R, Kris-Etherton P, SJ et al. (1997) Nutritional management of cardiovascular risk factors. Arch Intern Med 157: 169-177
55. McElduff P, Dobson A (1997) How much alcohol and how often? Population based case-control study of alcohol consumption and risk of maior coronary events. BMJ 314: 1159-64
56. Meydani M (1995) Vitamin E. Lancet 345: 170-175
57. Neaton J, Grimm R, Prineas R, Stamler J, Grandits G, Elmer P, Cutler J, Flack J, Schoenberger J, McDonald R, Lewis C, Liebson P, Group ftToMHSR (1993) Treatment of mild hypertension study. Final results. JAMA 270: 713-724
58. Nygard O, Nordrehaug J, Refsum H, Ueland P, Farstad M, Vollset S (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337: 230-236
59. Ornish D, Brown SE, Scherwiz LW, Billings JH, Arrmstrong WT, Ports TA, McLanahan SM, Kirkeeide RS, Brand RJ, Gould KL (1990) Can lifestyle changes reverse coronary heart disease. The Lifestyle Heart Trial. Lancet 336: 129-133
60. Pickering T (1997) Lessons from the trials of Hypertension, Phase II. Arch Int Med 157: 596-597
61. Pott E (1991) Nichtraucherschutz in Deutschland. In: Gleichmann U, Mannebach H, Gleichmann S (Hrsg.) Herausforderung Atherosklerose in den 90ern. Gesundheit fördern - Krankheit mindern. Steinkopff, Darmstadt
62. Puddey IB, Parker M, Beilin L, Vandongen R, Masarei J (1992) Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweght men. Hypertension 20: 533-541
63. Rapola J, Virtamo J, Ripatti S, Huttunen J, Albanes D, Taylor P, Heinonen O (1997) Randomized trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349: 1715-1720
64. Rimm E, Stampfer M, Ascherio A, Giovannuci E, Colditz G, Willet W (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328: 1450-1456
65. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-808
66. Rossouw JE, Lewis B, Rifkind BM (1990) The value of lowering cholesterol after myocardial infarction. N Engl J Med 323: 1112-1119
67. Ruppert M, Diehl J, Kolloch R, Kraft K, Overlack A, Stumpe K (1990) Dietary sodium restriction increases serum total and LDL-cholesterol in salt sensitive and salt-resistant normotensive adults. 13th Scientific Meeting, International Society of Hypertension. Abstr IA, 1:
68. Schotte D, Stunkard A (1990) The effect of weight reduction on blood pressure in 301 obese patients. Arch Intern Med 150: 1701-1704
69. Schuler G, Hambrecht R, Schlierf G, Grunze M, Methfessel, S, Huauer K, Kübler W (1992) Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensives physical exercise and low fat diet. JACC 19: 34-42
70. Schulte H, Assmann G (1988) Ergebnisse der "Prospective Cardiovascular Münster" (Procam) Studie. Soz Praeventivmed 33: 3236
71. Seidel D, Cremers P (1986) Guidelines for the clinical evaluation of risk factors: first report from the Göttinger risk, Inzidenz and prevalence study. Atherosclerosis Reviews 14: 61-69
72. Siegrist K (1994) Widerstände gegen Lebensstiländerungen. In: Kolenda K-D (Hrsg.) Lebensstil und koronare Herzkrankheit. PERIMED-spitta, Balingen, S 30-36
73. Stamler R, Stamler J, Grimm R, Dyer R, Gosch F, Berman R, Elmer P, Fishman J, Van Heel N, Civinelli J, Hoeksema R (1985) Nonpharmocological control of hypertension. Prev Med 14: 336-345
74. Stampfer M, Hennekens C, Manson J, Colditz G, Rosner B, Willet C (1993) Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 330: 1444-1449
75. Stephens N (1996) Anti-oxydant therapy for ischemic heart disease: where do we stand? Lancet 349: 1710-1711
76. Stille W (1977) Arteriosklerose - eine Infektion durch Chlamydia pneumoniae. Dtsch med Wschr 122: 1086-1091
77. TOHP: and Group TToHPCR (1992) The effects of nonpharmacologic interventions on blood pressure of persons with high normal values. Results of the trials of hypertension prevention, phase I. JAMA 267: 1213-1220
78. TOPH II TToHPCRG (1997) Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. Arch Intern Med 150: 153-162
79. Ummenhofer C(1994) Sodium and Hypertension - Results of Randomized Trials. Zusammenfassung eines internationalen Symposions. Freiburg i.Br.: S 42-48
80. Vandongen R, Puddey I (1994) Alcohol intake and blood pressure. Blackwell, Oxford
81. Wechsler (1997) Adipositas. Dtsch Ärzteblatt
82. WHO/ISH, Guidelines and Sub-Committee (1993) 1993 guidelines for the managment of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 11: 905-918
83. Witztum J, Steinberg D (1991) Role of oxydized low density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792
84. Wolfram G (1994) Ist der Wert der antioxydativen Vitamine etabliert? Internist 35: 1117-1123
85. Zeiher A (1996) Endothelial vasodilator dysfunction: pathogenetic link to myocardial ischemia or epiphenomenon? Lancet 348 (suppl I): s10-s12
86. Zeiher A, Drexler H, Wollschläger H, Just H (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83: 391-401